Trulieve Cannabis Corp. (TRLV)
NYSE: TRLV · Real-Time Price · USD
10.67
+0.30 (2.89%)
At close: Oct 9, 2026, 4:00 PM EDT
10.55
-0.12 (-1.12%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Trulieve Cannabis Market Cap
Trulieve Cannabis has a market cap or net worth of $2.05 billion as of October 9, 2026. It is the 6,645th most valuable company in the world and the 1,759th biggest in the United States.
Market Cap
2.05B
Enterprise Value
2.31B
1-Year Change
n/a
Global Rank
Country Rank
#1,759 United States
Category
ChartMarket Cap Chart
Since June 10, 2026, Trulieve Cannabis's market cap has decreased from $2.21B to $2.05B, a decrease of -7.09%. That is a compound annual growth rate of -19.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.05B | 2.89% |
| Oct 8, 2026 | 2.00B | -3.81% |
| Oct 7, 2026 | 2.08B | 1.22% |
| Oct 6, 2026 | 2.05B | - |
| Oct 5, 2026 | 2.05B | -0.65% |
| Oct 2, 2026 | 2.06B | -1.38% |
| Oct 1, 2026 | 2.09B | -0.28% |
| Sep 30, 2026 | 2.10B | -12.16% |
| Sep 29, 2026 | 2.39B | 0.56% |
| Sep 28, 2026 | 2.38B | 1.07% |
| Sep 25, 2026 | 2.35B | -0.49% |
| Sep 24, 2026 | 2.36B | -2.15% |
| Sep 23, 2026 | 2.41B | 0.56% |
| Sep 22, 2026 | 2.40B | 8.44% |
| Sep 21, 2026 | 2.21B | 3.88% |
| Sep 18, 2026 | 2.13B | -4.98% |
| Sep 17, 2026 | 2.24B | 0.87% |
| Sep 16, 2026 | 2.22B | -0.43% |
| Sep 15, 2026 | 2.23B | -0.17% |
| Sep 14, 2026 | 2.24B | 2.74% |
| Sep 11, 2026 | 2.18B | -0.09% |
| Sep 10, 2026 | 2.18B | -3.83% |
| Sep 9, 2026 | 2.27B | -5.31% |
| Sep 8, 2026 | 2.39B | 2.64% |
| Sep 4, 2026 | 2.33B | 1.00% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.50B |
| Liquidia | 2.48B |
| HUTCHMED (China) | 2.47B |
| Prestige Consumer Healthcare | 2.31B |
| Bausch Health Companies | 2.27B |
| BioCryst Pharmaceuticals | 2.19B |
| Perrigo Company | 2.08B |
| Alvotech | 2.06B |